References
- http://www.cbsnews.com/stories/2010/04/16/60minutes/main6402854_page7.shtml?tag=contentMain;contentBody
- http://www.thestowefoundation.org/
- Verma A, Berger JR. ALS syndrome in patients with HIV-1 infection. J Neurol Sci. 2006;240:59–64.
- http://investor.neuralstem.com/phoenix.zhtml?c=203908&p=irol-newsArticle&ID=1377437&highlight
- Kaufmann P, Thompson JL, Levy G, . Phase II trial of CoQ10 in ALS finds insufficient evidence to justify phase III. Ann Neurol. 2009;66:235–44.
- Herberlin LL, Drisko J, Barohn R, . Intravenous glutathione in ALS. Amyotroph Lateral Scler. 2004;5:117.
- Orrell RW, Lane RJM, Ross M. Antioxidant treatment for amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database of Systematic Reviews2007_Issue 1. Art. No.: CD002829. DOI: 10.1002/14651858.CD002829.pub4.